SCHEMBL6328121

SCHEMBL6328121

CC(=O)N1C(=O)C(=C(Cl)c2ccc(Cl)cc2)c2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 3/20 0.54
PRKAG1 P54619 5/20 0.44
PRKAA2 P54646 5/20 0.44
PRKAB1 Q9Y478 5/20 0.44
MAPT P10636 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
ALDH1A1 P00352 2/20 0.43
USP2 O75604 1/20 0.43
CASP1 P29466 1/20 0.43
BRCA1 P38398 1/20 0.43
P2RX4 Q99571 1/20 0.40
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
CASP3 P42574 1/20 0.38
MCL1 Q07820 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6328120 1.00 CES1 (0.54) CES1PRKAG1PRKAA2PRKAB1MAPT
SCHEMBL6328148 0.90 CES1 (0.58) CES1PRKAG1PRKAA2PRKAB1MAPT
SCHEMBL6328153 0.90 CES1 (0.58) CES1PRKAG1PRKAA2PRKAB1MAPT
SCHEMBL6321121 0.89 CES1 (0.54) CES1MAPTMEN1KMT2AALDH1A1
SCHEMBL6321119 0.89 CES1 (0.54) CES1MAPTMEN1KMT2AALDH1A1
SCHEMBL8016552 0.88 CES1 (0.52) CES1MAPTMEN1KMT2AALDH1A1
SCHEMBL8016555 0.88 CES1 (0.52) CES1MAPTMEN1KMT2AALDH1A1
SCHEMBL6320616 0.86 CES1 (0.50) CES1PRKAG1PRKAA2PRKAB1MAPT
SCHEMBL6320761 0.86 CES1 (0.50) CES1MAPTMEN1KMT2AALDH1A1
SCHEMBL6320618 0.86 CES1 (0.50) CES1PRKAG1PRKAA2PRKAB1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6855710-B2 Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-02-15 US disclosed